Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fresenius Medical Care Deutschland GmbH | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to characterise, in detail, the cardiac structure, function and perfusion of those on haemodialysis and haemodiafiltration, comparing the two modalities to ascertain if haemodiafiltration provides relative myocardial protection compared to conventional haemodialysis.
Trial Configuration: Non-blinded crossover pilot study Setting: Secondary care Sample size estimate: This is a pilot study therefore power calculations are not appropriate. A group size of 12 participants has been selected for feasibility.
Number of participants: 12 patients to complete study Description of interventions
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Online haemodiafiltration | Active Comparator |
| |
| Haemodialysis | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| online Hemodiafiltration | Other | Effects of high efficiency online hemodiafiltration on cardiac structure, function and myocardial perfusion were compared with standard haemodialysis. |
| Measure | Description | Time Frame |
|---|---|---|
| The change in global cardiac perfusion (ml/min/100g) between conventional HD and HDF | 2 week |
| Measure | Description | Time Frame |
|---|---|---|
| The change in segmental cardiac perfusion during conventional HD and HDF | 2 week | |
| The change in global and segmental cardiac function as measured by phase-contrast MRI | 2 week | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Change in ideal dry weight in 4 weeks prior to recruitment
Instability on dialysis in 4 weeks prior to recruitment leading to either:
Dialysed via a synthetic line or graft
Qa < 500ml/min
NYHA Stage IV heart failure
Active infection or malignancy
Contraindication to MRI scanning including claustrophobia
Mental incapacity to consent
Pregnancy or planning pregnancy
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017583 | Hemodiafiltration |
| D006435 | Renal Dialysis |
| D003956 | Dialysis |
| ID | Term |
|---|---|
| D017582 | Renal Replacement Therapy |
| D013812 | Therapeutics |
| D016060 | Sorption Detoxification |
| D006440 | Hemofiltration |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Hemodialysis | Other | Effects of high efficiency online hemodiafiltration on cardiac structure, function and myocardial perfusion were compared with standard haemodialysis. |
|
|
| Serum markers of cardiac damage, renal, liver function, clotting, full blood count |
Bloods collected at the end of 2 week study period on the scan days on HD and HDF |
| 2 weeks |
| Reported tolerability of cardiac MRI scanning whilst having dialysis | On 2 MRI study days | On 2 MRI study days |
| D005112 |
| Extracorporeal Circulation |
| D013514 | Surgical Procedures, Operative |
| D002623 | Chemistry Techniques, Analytical |
| D008919 | Investigative Techniques |
| D055598 | Chemical Phenomena |